Economic burden of hematologic adverse events (AEs) associated with metastatic colorectal cancer (mCRC) treatment in the United States (US).
2016 ◽
Vol 34
(15_suppl)
◽
pp. e15008-e15008
Keyword(s):
2016 ◽
Vol 20
(1)
◽
pp. 54-62
◽
2018 ◽
Vol 60
(4)
◽
pp. 955-963
◽
Keyword(s):
2015 ◽
Vol 15
(1)
◽
pp. 66-76
◽
Keyword(s):
2015 ◽
Vol 33
(15_suppl)
◽
pp. e14554-e14554
2016 ◽
Vol 34
(15_suppl)
◽
pp. e15082-e15082
Keyword(s):